OpenFilings

Jazz Pharmaceuticals plc

Form10-Q

Report Period2026-06-30

Date Filed2026-08-03

Time Filed16:08:34

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar